Common Contracts
2 similar Retention Bonus Letter contracts by ARCA Biopharma, Inc.
ARCA BIOPHARMA, INC. AMENDMENT TO RETENTION BONUS LETTERRetention Bonus Letter • December 4th, 2023 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
This amendment (the “Amendment”) is entered into effective as of December 4, 2023 by and between C. Jeffrey Dekker (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).
ARCA BIOPHARMA, INC. AMENDMENT TO RETENTION BONUS LETTERRetention Bonus Letter • December 4th, 2023 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
This amendment (the “Amendment”) is entered into effective as of December 4, 2023 by and between Thomas A. Keuer (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).
